|
|
Substance Name: Alfuzosin hydrochloride [USAN:USP]
RN: 81403-68-1
UNII: 75046A1XTN
InChIKey: YTNKWDJILNVLGX-UHFFFAOYSA-N
Classification Code
- Antihypertensive (alpha-Blocker)
Molecular Formula
- C19-H27-N5-O4.Cl-H
Molecular Weight
- 425.9142
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Alfuzosin hydrochloride [USAN:USP]
Synonyms
- (+-)-N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furamide monohydrochloride
- 2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)-
- Alfoten
- Alfuzosin HCl
- Alfuzosin hydrochloride
- SL 77 499-10
- SL 77499-10
- SL77.0499-10
- UNII-75046A1XTN
- Urion
- Uroxatral
- Xatral
Systematic Name
- 2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)-
Registry Numbers
CAS Registry Number
- 81403-68-1
FDA UNII
- 75046A1XTN
Other Registry Number
- 133880-44-1
Related Registry Number
- 81403-80-7 (Parent)
System Generated Number
- 0081403681
Molecular Formulas
Molecular Formula
- C19-H27-N5-O4.Cl-H
Molecular Formula Fragments
- C19-H27-N5-O4
- Cl-H
- COMPONENT
Structure Descriptors
InChI
InChI=1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1HInChIKey
YTNKWDJILNVLGX-UHFFFAOYSA-NSmiles
Cl.COc1cc2nc(nc(N)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | > 200mg/kg (200mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 2569, 2000. | |
mouse | LD50 | intravenous | 235mg/kg (235mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 2569, 2000. | |
rat | LD50 | intravenous | 146mg/kg (146mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 2569, 2000. |